Western blotting showed that after treatment with luteolin, the expression of FOXP3 in the lungs was also upregulated compared with the CLP group (Figure 2(c)), indicating that luteolin promotes Treg differentiation and the expression of FOXP3 in ARDS. The gene discussed is FOXP3; the disease is acute respiratory distress syndrome.